Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flepp

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Heart (British Cardiac Society)|March 31, 2005
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trialD Hürlimann, R Chenevard, F Ruschitzka, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
AIDS (London, England)|November 8, 2001
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly, S Vora, P Rizzardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapyL Magenta, S Dell-Kuster, W O Richter, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Heart (British Cardiac Society)|March 31, 2005
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trialD Hürlimann, R Chenevard, F Ruschitzka, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
AIDS (London, England)|November 8, 2001
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly, S Vora, P Rizzardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapyL Magenta, S Dell-Kuster, W O Richter, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Pageof 7